Revision as of 09:39, 1 November 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacol...← Previous edit | Revision as of 08:32, 9 December 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacol...Next edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | | Verifiedfields = changed | ||
| verifiedrevid = |
| verifiedrevid = 464210715 | ||
| type = mab | | type = mab | ||
| image = | | image = |
Revision as of 08:32, 9 December 2011
Pharmaceutical compoundMonoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | beta-amyloid |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C6552H10158N1730O2090S52 |
Molar mass | 148.3 kDa g·mol |
(what is this?) (verify) |
Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.
Ponezumab was developed by Pfizer Inc.
References
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Ponezumab" (PDF). American Medical Association.
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
---|---|---|---|---|---|---|---|---|---|
Bone |
| ||||||||
Musculoskeletal |
| ||||||||
Circulatory |
| ||||||||
Neurologic |
| ||||||||
Angiogenesis inhibitor |
| ||||||||
Growth factor |
| ||||||||
|
This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it. |
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |